Da An Gene Co Ltd of Sun Yat-Sen University (SHE:002030) — Stock Price
Da An Gene Co Ltd of Sun Yat-Sen University (SHE:002030) is currently trading at CN¥5.64 CNY, up 0.36% today. Over the past 52 weeks, shares have ranged between CN¥4.88 and CN¥7.71. This page tracks Da An Gene Co Ltd of Sun Yat-Sen University's live share price on the SHE exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. To see how efficiently this company converts equity into cash flow, see Da An Gene Co Ltd of Sun Yat-Sen Univers operating cash flow efficiency.
Da An Gene Co Ltd of Sun Yat-Sen University (002030) Stock Price Chart — Daily History & Trading Volume
The chart below tracks Da An Gene Co Ltd of Sun Yat-Sen University's daily closing share price and trading volume on the SHE exchange over the past year, giving a clear view of recent price momentum and liquidity.
Da An Gene Co Ltd of Sun Yat-Sen University Income Statement — Revenue, Profit & Earnings by Year
Da An Gene Co Ltd of Sun Yat-Sen University's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Revenue | CN¥757.66 Million | CN¥853.02 Million | CN¥1.18 Billion | CN¥12.05 Billion | CN¥7.66 Billion |
| Cost of Revenue | CN¥512.17 Million | CN¥629.58 Million | CN¥801.12 Million | CN¥3.62 Billion | CN¥1.96 Billion |
| Gross Profit | CN¥245.49 Million | CN¥223.44 Million | CN¥379.78 Million | CN¥8.43 Billion | CN¥5.70 Billion |
| Research & Development | CN¥186.34 Million | CN¥336.24 Million | CN¥302.33 Million | CN¥702.40 Million | CN¥508.80 Million |
| SG&A | CN¥102.05 Million | CN¥125.19 Million | CN¥127.85 Million | CN¥306.88 Million | CN¥333.39 Million |
| Total Operating Expenses | CN¥1.05 Billion | CN¥1.29 Billion | CN¥258.15 Million | CN¥2.10 Billion | CN¥1.58 Billion |
| Operating Income | CN¥-297.16 Million | CN¥-1.07 Billion | CN¥121.62 Million | CN¥6.33 Billion | CN¥4.13 Billion |
| EBITDA | — | CN¥-374.26 Million | CN¥-11.82 Million | CN¥6.35 Billion | CN¥4.09 Billion |
| EBIT | — | CN¥-713.02 Million | CN¥-356.04 Million | CN¥6.08 Billion | CN¥3.90 Billion |
| Interest Expense | CN¥4.19 Million | CN¥9.74 Million | CN¥10.63 Million | CN¥14.37 Million | CN¥14.90 Million |
| Income Before Tax | CN¥-756.99 Million | CN¥-1.07 Billion | CN¥113.54 Million | CN¥6.32 Billion | CN¥4.12 Billion |
| Income Tax Expense | — | CN¥-132.05 Million | CN¥41.80 Million | CN¥891.38 Million | CN¥501.59 Million |
| Net Income | CN¥-744.38 Million | CN¥-925.17 Million | CN¥104.66 Million | CN¥5.41 Billion | CN¥3.62 Billion |
Da An Gene Co Ltd of Sun Yat-Sen University Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes Da An Gene Co Ltd of Sun Yat-Sen University's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Assets | CN¥8.51 Billion | CN¥9.58 Billion | CN¥11.02 Billion | CN¥14.76 Billion | CN¥10.34 Billion |
| Total Current Assets | CN¥2.84 Billion | CN¥3.78 Billion | CN¥5.31 Billion | CN¥8.77 Billion | CN¥5.98 Billion |
| Cash & Equivalents | — | — | — | — | — |
| Short-term Investments | CN¥593.89 Million | CN¥63.00 Million | CN¥1.40 Billion | CN¥480.90 Million | CN¥380.01 Million |
| Net Receivables | CN¥745.54 Million | CN¥1.30 Billion | CN¥2.17 Billion | CN¥4.19 Billion | CN¥2.34 Billion |
| Inventory | CN¥147.58 Million | CN¥198.21 Million | CN¥239.52 Million | CN¥369.60 Million | CN¥493.72 Million |
| Property, Plant & Equipment | — | — | — | — | CN¥863.06 Million |
| Goodwill | CN¥0.00 | CN¥0.00 | CN¥0.00 | CN¥0.00 | CN¥0.00 |
| Total Liabilities | CN¥1.15 Billion | CN¥1.43 Billion | CN¥1.86 Billion | CN¥3.14 Billion | CN¥2.68 Billion |
| Total Current Liabilities | CN¥1.01 Billion | CN¥1.29 Billion | CN¥1.72 Billion | CN¥2.97 Billion | CN¥2.52 Billion |
| Long-term Debt | CN¥0.00 | CN¥0.00 | CN¥0.00 | CN¥0.00 | CN¥0.00 |
| Net Debt | — | CN¥-715.10 Million | CN¥-646.75 Million | CN¥-2.37 Billion | CN¥-1.81 Billion |
| Total Stockholder Equity | CN¥7.14 Billion | CN¥7.88 Billion | CN¥8.88 Billion | CN¥11.30 Billion | CN¥7.35 Billion |
| Retained Earnings | CN¥3.87 Billion | CN¥4.61 Billion | CN¥5.56 Billion | CN¥7.93 Billion | CN¥4.62 Billion |
Da An Gene Co Ltd of Sun Yat-Sen University Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how Da An Gene Co Ltd of Sun Yat-Sen University generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Cash Flow | CN¥319.49 Million | CN¥300.33 Million | CN¥845.76 Million | CN¥4.15 Billion | CN¥3.30 Billion |
| Capital Expenditures | CN¥239.00 Million | CN¥174.41 Million | CN¥572.77 Million | CN¥1.50 Billion | CN¥658.75 Million |
| Free Cash Flow | CN¥80.49 Million | CN¥125.92 Million | CN¥207.34 Million | CN¥2.65 Billion | CN¥2.65 Billion |
| Investing Cash Flow | — | CN¥-217.39 Million | CN¥-129.34 Million | CN¥-1.96 Billion | CN¥-1.38 Billion |
| Financing Cash Flow | — | CN¥-205.96 Million | CN¥-2.32 Billion | CN¥-1.79 Billion | CN¥-626.55 Million |
| Dividends Paid | CN¥8.46 Million | CN¥27.88 Million | CN¥2.46 Billion | CN¥1.56 Billion | CN¥482.43 Million |
| Stock-Based Compensation | — | — | — | — | — |
| Depreciation | CN¥299.67 Million | CN¥350.36 Million | CN¥365.28 Million | CN¥298.44 Million | CN¥192.02 Million |
| Change in Cash | CN¥-363.71 Million | CN¥-121.90 Million | CN¥-1.60 Billion | CN¥427.93 Million | CN¥1.30 Billion |
Da An Gene Co Ltd of Sun Yat-Sen University Earnings History — EPS Actual vs. Analyst Estimates
Track Da An Gene Co Ltd of Sun Yat-Sen University's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| Aug 31, 2026 | -0.02 | — | — |
| Apr 29, 2026 | -0.07 | — | — |
| Oct 31, 2025 | 0.03 | — | — |
| Aug 30, 2025 | -0.17 | — | — |
| Apr 29, 2025 | 0.04 | — | — |
| Mar 29, 2025 | -0.30 | — | — |
| Oct 30, 2024 | -0.07 | — | — |
| Aug 31, 2024 | -0.03 | — | — |